339 related articles for article (PubMed ID: 20452361)
1. Binding of the MLL PHD3 finger to histone H3K4me3 is required for MLL-dependent gene transcription.
Chang PY; Hom RA; Musselman CA; Zhu L; Kuo A; Gozani O; Kutateladze TG; Cleary ML
J Mol Biol; 2010 Jul; 400(2):137-44. PubMed ID: 20452361
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of MLL PHD3 and RNA recognition by the Cyp33 RRM domain.
Hom RA; Chang PY; Roy S; Musselman CA; Glass KC; Selezneva AI; Gozani O; Ismagilov RF; Cleary ML; Kutateladze TG
J Mol Biol; 2010 Jul; 400(2):145-54. PubMed ID: 20460131
[TBL] [Abstract][Full Text] [Related]
3. The PHD3 domain of MLL acts as a CYP33-regulated switch between MLL-mediated activation and repression .
Park S; Osmers U; Raman G; Schwantes RH; Diaz MO; Bushweller JH
Biochemistry; 2010 Aug; 49(31):6576-86. PubMed ID: 20677832
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF.
Li H; Ilin S; Wang W; Duncan EM; Wysocka J; Allis CD; Patel DJ
Nature; 2006 Jul; 442(7098):91-5. PubMed ID: 16728978
[TBL] [Abstract][Full Text] [Related]
5. Evolving Catalytic Properties of the MLL Family SET Domain.
Zhang Y; Mittal A; Reid J; Reich S; Gamblin SJ; Wilson JR
Structure; 2015 Oct; 23(10):1921-1933. PubMed ID: 26320581
[TBL] [Abstract][Full Text] [Related]
6. Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia.
Risner LE; Kuntimaddi A; Lokken AA; Achille NJ; Birch NW; Schoenfelt K; Bushweller JH; Zeleznik-Le NJ
J Biol Chem; 2013 Oct; 288(41):29901-10. PubMed ID: 23990460
[TBL] [Abstract][Full Text] [Related]
7. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.
Zhu L; Li Q; Wong SH; Huang M; Klein BJ; Shen J; Ikenouye L; Onishi M; Schneidawind D; Buechele C; Hansen L; Duque-Afonso J; Zhu F; Martin GM; Gozani O; Majeti R; Kutateladze TG; Cleary ML
Cancer Discov; 2016 Jul; 6(7):770-83. PubMed ID: 27154821
[TBL] [Abstract][Full Text] [Related]
8. The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations.
Huang G; Zhao X; Wang L; Elf S; Xu H; Zhao X; Sashida G; Zhang Y; Liu Y; Lee J; Menendez S; Yang Y; Yan X; Zhang P; Tenen DG; Osato M; Hsieh JJ; Nimer SD
Blood; 2011 Dec; 118(25):6544-52. PubMed ID: 22012064
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2.
Peña PV; Davrazou F; Shi X; Walter KL; Verkhusha VV; Gozani O; Zhao R; Kutateladze TG
Nature; 2006 Jul; 442(7098):100-3. PubMed ID: 16728977
[TBL] [Abstract][Full Text] [Related]
10. c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.
Jin S; Zhao H; Yi Y; Nakata Y; Kalota A; Gewirtz AM
J Clin Invest; 2010 Feb; 120(2):593-606. PubMed ID: 20093773
[TBL] [Abstract][Full Text] [Related]
11. Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark.
Revenko AS; Kalashnikova EV; Gemo AT; Zou JX; Chen HW
Mol Cell Biol; 2010 Nov; 30(22):5260-72. PubMed ID: 20855524
[TBL] [Abstract][Full Text] [Related]
12. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger.
Wang GG; Song J; Wang Z; Dormann HL; Casadio F; Li H; Luo JL; Patel DJ; Allis CD
Nature; 2009 Jun; 459(7248):847-51. PubMed ID: 19430464
[TBL] [Abstract][Full Text] [Related]
13. Solution NMR structure and histone binding of the PHD domain of human MLL5.
Lemak A; Yee A; Wu H; Yap D; Zeng H; Dombrovski L; Houliston S; Aparicio S; Arrowsmith CH
PLoS One; 2013; 8(10):e77020. PubMed ID: 24130829
[TBL] [Abstract][Full Text] [Related]
14. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
Milne TA; Martin ME; Brock HW; Slany RK; Hess JL
Cancer Res; 2005 Dec; 65(24):11367-74. PubMed ID: 16357144
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.
Paggetti J; Largeot A; Aucagne R; Jacquel A; Lagrange B; Yang XJ; Solary E; Bastie JN; Delva L
Oncogene; 2010 Sep; 29(36):5019-31. PubMed ID: 20581860
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of nucleosome recognition and modification by MLL methyltransferases.
Xue H; Yao T; Cao M; Zhu G; Li Y; Yuan G; Chen Y; Lei M; Huang J
Nature; 2019 Sep; 573(7774):445-449. PubMed ID: 31485071
[TBL] [Abstract][Full Text] [Related]
17. Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia.
Wang E; Kawaoka S; Yu M; Shi J; Ni T; Yang W; Zhu J; Roeder RG; Vakoc CR
Proc Natl Acad Sci U S A; 2013 Mar; 110(10):3901-6. PubMed ID: 23412334
[TBL] [Abstract][Full Text] [Related]
18. Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 Di- and tri-methylation on target genes and transformation potential.
Kuntimaddi A; Achille NJ; Thorpe J; Lokken AA; Singh R; Hemenway CS; Adli M; Zeleznik-Le NJ; Bushweller JH
Cell Rep; 2015 May; 11(5):808-20. PubMed ID: 25921540
[TBL] [Abstract][Full Text] [Related]
19. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression.
Shi X; Hong T; Walter KL; Ewalt M; Michishita E; Hung T; Carney D; Peña P; Lan F; Kaadige MR; Lacoste N; Cayrou C; Davrazou F; Saha A; Cairns BR; Ayer DE; Kutateladze TG; Shi Y; Côté J; Chua KF; Gozani O
Nature; 2006 Jul; 442(7098):96-9. PubMed ID: 16728974
[TBL] [Abstract][Full Text] [Related]
20. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
